Variant report
Variant | nsv970165 |
---|---|
Chromosome Location | chr6:132593252-132594252 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:132594092..132595874-chr6:132598411..132600754,3 | K562 | blood: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-TAAR8-2 | chr6:132593121-132594471 | NONHSAT114964 |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs75887813 | chr6:132593257-132593258 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs541147579 | chr6:132593310-132593311 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs564052598 | chr6:132593316-132593317 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs536740237 | chr6:132593317-132593318 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs574418641 | chr6:132593411-132593412 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs543290527 | chr6:132593429-132593430 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs9493262 | chr6:132593433-132593434 | Enhancers Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs529157640 | chr6:132593439-132593440 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs548927971 | chr6:132593444-132593445 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs9493263 | chr6:132593448-132593449 | Enhancers Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs145611792 | chr6:132593454-132593455 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs9493264 | chr6:132593480-132593481 | Enhancers Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs571684752 | chr6:132593489-132593490 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs537642843 | chr6:132593492-132593493 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs373309507 | chr6:132593493-132593494 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs9493265 | chr6:132593501-132593502 | Enhancers Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs182902416 | chr6:132593519-132593520 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs148914714 | chr6:132593530-132593531 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs541718239 | chr6:132593566-132593567 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs386705957 | chr6:132593688-132593689 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs9493266 | chr6:132593689-132593690 | Enhancers Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs77727377 | chr6:132593694-132593695 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs545748679 | chr6:132593704-132593705 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs563174265 | chr6:132593745-132593746 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs9493267 | chr6:132593752-132593753 | Enhancers Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs563349037 | chr6:132593790-132593791 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs529120035 | chr6:132593817-132593818 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs56384202 | chr6:132593834-132593835 | Enhancers Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs559251356 | chr6:132593847-132593848 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs111751069 | chr6:132593860-132593861 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs551525424 | chr6:132593922-132593923 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs73541998 | chr6:132593965-132593966 | Enhancers Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs575134303 | chr6:132594053-132594054 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs186918415 | chr6:132594055-132594056 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
35 | rs151238012 | chr6:132594060-132594061 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
36 | rs192440516 | chr6:132594082-132594083 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
37 | rs77167423 | chr6:132594106-132594107 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
38 | rs58428348 | chr6:132594119-132594120 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs567210382 | chr6:132594128-132594129 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
40 | rs577292249 | chr6:132594134-132594135 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
41 | rs6933036 | chr6:132594152-132594153 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs577629217 | chr6:132594157-132594158 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
43 | rs528180912 | chr6:132594176-132594177 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
44 | rs536764805 | chr6:132594178-132594179 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
45 | rs117118487 | chr6:132594187-132594188 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
46 | rs374094789 | chr6:132594188-132594189 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
47 | rs376679839 | chr6:132594195-132594196 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
48 | rs542449053 | chr6:132594220-132594221 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
49 | rs183550805 | chr6:132594242-132594243 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Autism | 22495311 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Gastric cancer | 17908304 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Developmental delay | 19490664 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21785460 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Breast cancer | 17133270 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:132589600-132595800 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
2 | chr6:132590000-132595400 | Weak transcription | Aorta | Aorta |
3 | chr6:132592400-132596000 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
4 | chr6:132592600-132595400 | Weak transcription | Fetal Intestine Large | intestine |
5 | chr6:132592600-132595400 | Weak transcription | Fetal Intestine Small | intestine |
6 | chr6:132592600-132595600 | Weak transcription | Duodenum Mucosa | Duodenum |
7 | chr6:132592600-132595800 | Weak transcription | Fetal Muscle Leg | muscle |
8 | chr6:132592600-132596400 | Weak transcription | H9 Cell Line | embryonic stem cell |
9 | chr6:132592800-132595400 | Weak transcription | Stomach Mucosa | stomach |
10 | chr6:132593400-132594200 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
11 | chr6:132593800-132594000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
12 | chr6:132594000-132595800 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
13 | chr6:132594200-132599200 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |